Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Amgen drug combined with immunotherapy extends survival in lung cancer trial

The Amgen drug is currently approved for adults in the advanced stages of small cell lung cancer that has worsened despite chemotherapy, based on data showing that Imdelltra reduced the risk of death by 40%

Amgen drug combined with immunotherapy extends survival in lung cancer trial

We haven't written up this one. The Hindu - Sci-Tech has the full story — the link below goes straight to it.

Also reported by 2 other outlets

Read the original at thehindu.com →

More in Health & Medicine

More from Monday 26 October →